We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALTHE market cap is 16.23M. The company's latest EPS is EUR -0.0804 and P/E is -4.35.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.22M | 1M | 1.71M | 1.37M | 3.92M |
| Operating Income | -4.5M | -4.05M | -4.51M | -6.28M | -2.59M |
| Net Income | -3.79M | -3.91M | -3.76M | -4.96M | -3.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 10.51M | 10.55M | 11.83M | 13.94M | 18.66M |
| Total Liabilities | 10.59M | 13.78M | 13.1M | 13.4M | 13.02M |
| Total Equity | -80k | -3.24M | -1.27M | 545k | 5.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.69M | -3.32M | -3.88M | -5.27M | -2.49M |
| Investing | -317k | -192k | -524k | -740k | -213k |
| Financing | 4.53M | 4.41M | 4.56M | 6.03M | 7.99M |
| Market Cap | 16.23M |
| Price to Earnings Ratio | -4.35 |
| Price to Sales Ratio | 4.08 |
| Price to Cash Ratio | 2.05 |
| Price to Book Ratio | 2.83 |
| Dividend Yield | - |
| Shares Outstanding | 45.73M |
| Average Volume (1 week) | 93.09k |
| Average Volume (1 Month) | 58.98k |
| 52 Week Change | -41.23% |
| 52 Week High | 0.686 |
| 52 Week Low | 0.30 |
| Spread (Intraday) | 0.01 (3.66%) |
| Company Name | Theraclion |
| Address |
240 avenue pierre brossolette malakoff, hauts-de-seine 92240 |
| Website | https://www.theraclion.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
